Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer

BACKGROUND: The objective of the present study was to examine the prognostic and predictive significance of the apoptosis-related marker Fas ligand (FasL):Fas ratio in breast cancer. METHODS: Tumour biopsies from 215 primary invasive breast cancer patients were examined for the expression of FasL an...

Descripción completa

Detalles Bibliográficos
Autores principales: Reimer, Toralf, Koczan, Dirk, Müller, Heiner, Friese, Klaus, Thiesen, Hans-Jürgen, Gerber, Bernd
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC125304/
https://www.ncbi.nlm.nih.gov/pubmed/12223126
http://dx.doi.org/10.1186/bcr456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC125304/
https://www.ncbi.nlm.nih.gov/pubmed/12223126
http://dx.doi.org/10.1186/bcr456

Ejemplares similares